GOLDMAN SACHS GROUP INC

Position in SABS — SAB Biotherapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$746,089

+$309,699 QoQ

Shares Held

191,305

+67.9% QoQ

Ownership

0.210%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#34

of 86 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. SABS ranks #272 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$746,089	191,305	+67.9%	Shares	Defined	2026-08-14
2026-03-31	$436,390	113,940	+121.9%	Shares	Defined	2026-05-15
2025-12-31	$192,041	51,348	+357.6%	Shares	Defined	2026-03-25
2025-09-30	$22,554	11,221	-11.1%	Shares	Defined	2025-11-14
2022-09-30	$8,845	12,618	-12.8%	Shares	Defined	2024-05-14
2022-06-30	$20,969	14,462	-6.7%	Shares	Defined	2024-05-14
2022-03-31	$58,257	15,494	+6.9%	Shares	Defined	2022-05-16
2021-12-31	$113,159	14,489	—	Shares	Defined	2022-02-17
2021-09-30 BCYP	—	55,000	-25.1%	Shares	Defined	2022-01-20
2021-06-30 BCYP	—	73,415	0.0%	Shares	Defined	2021-08-13
2021-03-31 BCYP	—	73,415	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.